SEC Form 4 · accession 0001171843-17-002114
PALISADE BIO, INC. · PALI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stanley Westreich
Director
Period of report
Apr 11, 2017
Accepted (ET)
Apr 13, 2017 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001357459
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase OptionF1 | $4.96 | Apr 11, 2017 | A | 33,408 | A | Apr 11, 2017 | Apr 11, 2024 | Common Stock | 33,408 | 33,408 | D |
Explanation of responses
- F1On April 11, 2017, Neuralstem issued a conditional grant to reporting person for services rendered as a director for the 2016 fiscal board year. The grant is 100% vested on the grant date and is being made on a conditional basis pursuant to NASDAQ market rules and will not be exercisable and will be subject to forfeiture if applicable shareholder approval is not received.